Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
2007年8月23日 - 8:00PM
PRニュース・ワイアー (英語)
SOUTH SAN FRANCISCO, Calif., Aug. 23 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc. (NASDAQ:MGRM) announced today that
William D. Young, CEO and Chairman, is scheduled to present a
corporate overview at the Thomas Weisel Partners Healthcare
Conference 2007 on Wednesday, September 5, 2007 at 3:15 p.m.
(Eastern Time) at the Four Seasons Hotel in Boston, Massachusetts.
To access the live audio broadcast or the subsequent archived
recording, log on to http://www.monogrambio.com/ and go to the
investor relations section ("Investors/Media" tab) and click on the
"Events & Webcasts" link provided on the sidebar menu on the
page. About Monogram Biosciences, Inc. Monogram is advancing
individualized medicine by discovering, developing and marketing
innovative products to guide and improve treatment of serious
infectious diseases and cancer. The Company's products are designed
to help doctors optimize treatment regimens for their patients that
lead to better outcomes and reduced costs. The Company's technology
is also being used by numerous biopharmaceutical companies to
develop new and improved antiviral therapeutics and vaccines as
well as targeted cancer therapeutics. More information about the
Company and its technology can be found on its web site at
http://www.monogrambio.com/. Contacts: Alfred G. Merriweather Chief
Financial Officer Tel: 650 624-4576 Jeremiah Hall Feinstein Kean
Healthcare Tel: 415 677-2700 DATASOURCE: Monogram Biosciences, Inc.
CONTACT: Alfred G. Merriweather, Chief Financial Officer of
Monogram Biosciences, Inc., +1-650-624-4576, ; or Jeremiah Hall of
Feinstein Kean Healthcare, +1-415-677-2700,
Copyright
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 9 2024 まで 10 2024
Monogram Technologies (NASDAQ:MGRM)
過去 株価チャート
から 10 2023 まで 10 2024